Truist Financial
FSTX

Truist Financial’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Truist Financial’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-79,092
Closed -$397K – 2900
2021
Q4 		$397K Hold
79,092
– – ﹤0.01% 2162
2021
Q3 		$579K Buy
79,092
+33,000
+72% +$226K ﹤0.01% 1918
2021
Q2 		$396K Buy
46,092
+36,000
+357% +$307K ﹤0.01% 2211
2021
Q1 		$0 Buy
+10,092
New +$98K ﹤0.01% 2761

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Truist Financial's FSTX Position: Q1 2022 in Review

Truist Financial sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2022, closing a stake of 79,092 shares — an estimated $397K sold.

Truist Financial first reported a position in FSTX in Q1 2021 and held it in 4 quarters. The position peaked at $579K in Q3 2021. 40 funds tracked by Wall St. Rank hold FSTX as of Q1 2022.

  • Truist Financial reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 79,092 F-star Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $397K.
  • Truist Financial first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Truist Financial's F-star Therapeutics, Inc. Common Stock position peaked at $579K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.